SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052723
Filing Date
2020-11-10
Accepted
2020-11-10 06:49:38
Documents
86
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q beam-10q_20200930.htm 10-Q 2502181
2 EX-31.1 beam-ex311_6.htm EX-31.1 17838
3 EX-31.2 beam-ex312_7.htm EX-31.2 18222
4 EX-32.1 beam-ex321_10.htm EX-32.1 8538
5 EX-32.2 beam-ex322_9.htm EX-32.2 7950
  Complete submission text file 0001564590-20-052723.txt   9263472

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT beam-20200930.xml EX-101.INS 2170344
7 XBRL TAXONOMY EXTENSION SCHEMA beam-20200930.xsd EX-101.SCH 68821
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE beam-20200930_cal.xml EX-101.CAL 57873
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE beam-20200930_def.xml EX-101.DEF 239820
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE beam-20200930_lab.xml EX-101.LAB 454051
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE beam-20200930_pre.xml EX-101.PRE 405612
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 201299572
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences